Longitudinal Systemic Corticosteroid Utilisation for Asthma and Other Diseases in the United Kingdom from 1990 to 2018: A Population-based Cohort Analysis

Jaco Voorham, Andrew Menzies-Gow, Trung N Tran, Victoria Carter, Josef S Smolen, Arnaud Bourdin, Jatin Chapaner, Benjamin Emmanuel, David J Jackson, David B Price

Research output: Contribution to conferenceAbstractpeer-review

30 Downloads (Pure)

Abstract

Evidence of increased adverse event risk with systemic corticosteroid (SCS) use led patient management guidelines to embrace SCS-sparing treatment strategies. This study was conducted to describe time trends in SCS prescriptions and their relation to National Health Service (NHS) availability of SCS-sparing therapies.
Original languageEnglish
Number of pages3
Publication statusPublished - 19 Feb 2021
EventBTS WINTER MEETING - Online
Duration: 17 Feb 202120 Feb 2021
https://www.brit-thoracic.org.uk/education-and-events/winter-meeting-online/

Conference

ConferenceBTS WINTER MEETING
Period17/02/2120/02/21
Internet address

Bibliographical note

Funding: This work was supported by AstraZeneca.

Fingerprint

Dive into the research topics of 'Longitudinal Systemic Corticosteroid Utilisation for Asthma and Other Diseases in the United Kingdom from 1990 to 2018: A Population-based Cohort Analysis'. Together they form a unique fingerprint.

Cite this